Therapeutic Efficacy of Artemether-Lumefantrine, Artesunate-Amodiaquine, and Dihydroartemisinin Piperaquine for the Treatment of Uncomplicated Plasmodium falciparum Malaria in Nigerian Children

ational Malaria Elimination Programme0 个研究点目标入组 0 人开始时间: 2017年3月1日最近更新: 2023年5月29日

适应症

试验速览

暂无简介。

•Patients were included in the study if they satisfied the following criteria: Age 6 - 59 months, History of fever / presence of fever (temp >/= 37.5oC), Mono Plasmodium falciparum infection with parasitemia of 2,000 - 200,000 asexual forms per mL and Written informed consent, including readiness to comply with follow up visits by the child's parent or guardian.

•Patients were excluded from the study if they had any of the following: Signs of severe malaria or other danger signs, such as: 1. Hyperparasitaemia >200,000 2. Altered consciousness 3. Inability to sit or stand unsupported 4. Severe anaemia (Hb </= 5 g/dL) 5. Convulsions 6. Shock (systolic BP < 50 mmHg, and or presence of cold clammy extremities, fast thready pulses) 7. Inability to drink or breastfeed 8. Vomiting everything, Severe malnutrition, History of allergy to test drugs

发起方

ational Malaria Elimination Programme